Focus: Zeta Surgical is a public biotechnology company headquartered in Boston specializing in surgical guidance technology, with a focused pipeline in neuromodulation for treatment-resistant depression.
Profile data last refreshed 4h ago · AI intelligence enriched 6d ago
Hot — 47 jobs added in 30d
Net +35 (47 new, 12 removed). Aggressive expansion phase.
A niche opportunity for mission-driven clinical/regulatory professionals interested in neurotech who can tolerate early-stage financial opacity and constrained internal mobility.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Zeta Surgical
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Zeta Surgical's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Based on last 4 crawl cycles
Source: USCIS H-1B Employer Data Hub
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo